Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer
- 1 June 2004
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 13 (3), 173-183
- https://doi.org/10.1016/j.breast.2003.09.002
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe International Journal of Cell Cloning, 1998
- ERBB2 oncogene in human breast cancer and its clinical significanceEuropean Journal Of Cancer, 1998
- Neuregulins Promote Survival and Growth of Cardiac MyocytesJournal of Biological Chemistry, 1998
- The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactionsFEBS Letters, 1997
- Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinasesNature, 1997
- EGF-related peptides and their receptors in mammary gland development.Journal of Mammary Gland Biology and Neoplasia, 1997
- EGF-Related Peptides in the Pathophysiology of the Mammary GlandJournal of Mammary Gland Biology and Neoplasia, 1997
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987